262 related articles for article (PubMed ID: 15256459)
21. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ
J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126
[TBL] [Abstract][Full Text] [Related]
22. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells.
Côme MG; Skladanowski A; Larsen AK; Laurent G
Br J Cancer; 1999 Mar; 79(7-8):1090-7. PubMed ID: 10098741
[TBL] [Abstract][Full Text] [Related]
23. [The structure of cellular vaults, their role in the normal cell and in the multidrug resistance of cancer].
Szaflarski W; Nowicki M; Zabel M
Postepy Biochem; 2011; 57(3):266-73. PubMed ID: 22235652
[TBL] [Abstract][Full Text] [Related]
24. Nuclear localization of PTEN is regulated by Ca(2+) through a tyrosil phosphorylation-independent conformational modification in major vault protein.
Minaguchi T; Waite KA; Eng C
Cancer Res; 2006 Dec; 66(24):11677-82. PubMed ID: 17178862
[TBL] [Abstract][Full Text] [Related]
25. Major vault protein suppresses lung cancer cell proliferation by inhibiting STAT3 signaling pathway.
Bai H; Wang C; Qi Y; Xu J; Li N; Chen L; Jiang B; Zhu X; Zhang H; Li X; Yang Q; Ma J; Xu Y; Ben J; Chen Q
BMC Cancer; 2019 May; 19(1):454. PubMed ID: 31092229
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance.
Siva AC; Raval-Fernandes S; Stephen AG; LaFemina MJ; Scheper RJ; Kickhoefer VA; Rome LH
Int J Cancer; 2001 Apr; 92(2):195-202. PubMed ID: 11291045
[TBL] [Abstract][Full Text] [Related]
27. Vaults: a ribonucleoprotein particle involved in drug resistance?
Mossink MH; van Zon A; Scheper RJ; Sonneveld P; Wiemer EA
Oncogene; 2003 Oct; 22(47):7458-67. PubMed ID: 14576851
[TBL] [Abstract][Full Text] [Related]
28. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
[TBL] [Abstract][Full Text] [Related]
29. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413
[TBL] [Abstract][Full Text] [Related]
30. Modulation of daunorubicin cellular resistance by combination of P-glycoprotein blockers acting on drug efflux and intracellular drug sequestration in Golgi vesicles.
Merlin JL; Bour-Dill C; Marchal S; Ramacci C; Poullain MG; Giroux B
Cytometry; 2000 Sep; 41(1):62-72. PubMed ID: 10942898
[TBL] [Abstract][Full Text] [Related]
31. Specific inhibition of gene expression of lung resistance-related protein by short interfering RNA.
Li N; Qian XH; Wang ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):1-5. PubMed ID: 16495165
[TBL] [Abstract][Full Text] [Related]
32. [Hypoxia-inducible factor-1 alpha dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Wang HP
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):277-81. PubMed ID: 15842930
[TBL] [Abstract][Full Text] [Related]
33. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
34. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs.
Berger W; Elbling L; Micksche M
Int J Cancer; 2000 Oct; 88(2):293-300. PubMed ID: 11004683
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.
Schroeijers AB; Scheffer GL; Flens MJ; Meijer GA; Izquierdo MA; van der Valk P; Scheper RJ
Am J Pathol; 1998 Feb; 152(2):373-8. PubMed ID: 9466563
[TBL] [Abstract][Full Text] [Related]
36. On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis.
Ryu SJ; An HJ; Oh YS; Choi HR; Ha MK; Park SC
Cell Death Differ; 2008 Nov; 15(11):1673-80. PubMed ID: 18600231
[TBL] [Abstract][Full Text] [Related]
37. In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1.
Rajagopal A; Pant AC; Simon SM; Chen Y
Cancer Res; 2002 Jan; 62(2):391-6. PubMed ID: 11809686
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence-based assessment of LRP activity: a comparative study.
Durdux M; Grunwald D; Gautier T; Ronot X; Boutonnat J
Anticancer Res; 2004; 24(2B):725-32. PubMed ID: 15161018
[TBL] [Abstract][Full Text] [Related]
39. Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies.
Schroeijers AB; Scheffer GL; Reurs AW; Pijnenborg AC; Abbondanza C; Wiemer EA; Scheper RJ
J Histochem Cytochem; 2001 Nov; 49(11):1379-85. PubMed ID: 11668191
[TBL] [Abstract][Full Text] [Related]
40. Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis.
Raval-Fernandes S; Kickhoefer VA; Kitchen C; Rome LH
Cancer Res; 2005 Oct; 65(19):8846-52. PubMed ID: 16204055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
